Medical Sales Jobs Websites

Auxilium Announces Appointments to Enhance Leadership Team

admin — Mon, 06 Feb 2012 15:19:07 +0000

Andrew I. Koven Named Executive Vice President, Chief Administrative Officer and General Counsel Mark A. Glickman Named Senior Vice President, Sales MALVERN, Pa., Feb. 6, 2012 (HSMN NewsFeed) — Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ), a spe…
Biopharmaceuticals, Personnel
Auxilium Pharmaceuticals

Auxilium Announces Appointments to Enhance Leadership Team

ALung Technologies Raises $10 Million in Series B Financing

admin — Mon, 06 Feb 2012 14:29:54 +0000

Funding to support continued commercialization of the Hemolung Respiratory Assist System PITTSBURGH–(Healthcare Sales & Product management Network)–ALung Technologies, Inc., a top developer of advanced respiratory products, announced today that it has clos…
Devices, Venture Capital
ALung Technologies, Hemolung

ALung Technologies Raises $10 Million in Series B Financing

Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida

admin — Sat, 04 Feb 2012 04:17:00 +0000

DUBLIN, Ohio, Feb. THREE, 2012 (HSMN NewsFeed) — Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration’s (DEA) immediate suspension order of its Lakeland, Fla. DEA registration. U.S. District Court fo…
Biopharmaceuticals, Distribution
Cardinal Health

Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida

Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302

admin — Fri, 03 Feb 2012 12:10:03 +0000

* Threshold to receive $25 million upfront, plus further potential milestones and royalties * Deal provides Threshold option to co-commercialize in the United States * Phase THREE trial in soft tissue sarcoma on-going and randomized Phase II trial in pat…
Biopharmaceuticals, Oncology
Threshold Pharmaceuticals, Merck KGaA, TH-302, soft tissue sarcoma

Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302

Caris Diagnostics Announces Name Change to Miraca Life Sciences

admin — Fri, 03 Feb 2012 10:22:31 +0000

Company to Provide Same High-Quality Anatomic Pathology Services Under New Name TOKYO and IRVING, Texas, Feb. THREE, 2012 –(HSMN NewsFeed) — Caris Diagnostics, specializing in academic-caliber anatomic medical laboratory services, today announced a company name ch…
Diagnostics
Miraca Life Sciences, Caris Diagnostics

Caris Diagnostics Announces Name Change to Miraca Life Sciences

Prometheus Announces New Chief Commercial Officer

admin — Fri, 03 Feb 2012 05:37:33 +0000

SAN DIEGO, Feb. THREE, 2012 (HSMN NewsFeed) — Prometheus Laboratories Inc., a specialty pharma and diagnostic company, today announced the appointment of Anthony J. Yost as Senior Vice President and Chief Commercial Officer. Tony joins Prometheus…
Diagnostics, Personnel
Prometheus Laboratories

Prometheus Announces New Chief Commercial Officer

Ronnie Andrews Joins Life Technologies as President, Medical Sciences

admin — Thu, 02 Feb 2012 12:43:54 +0000

Leveraging 25-Plus Years Diagnostic Industry Experience, Andrews Will Shape Life Technologies Molecular Diagnostics Business CARLSBAD, Calif., Feb. TWO, 2012 (HSMN NewsFeed) — Life Technologies Corporation (NASDAQ: LIFE ) today announced that Ronnie An…
Diagnostics, Personnel
Life Technologies

Ronnie Andrews Joins Life Technologies as President, Medical Sciences

Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis

admin — Thu, 02 Feb 2012 08:11:10 +0000

Results Provide Basis for Landmark EXCITE ISR Trial Underway in United States COLORADO SPRINGS, Colo.–(Healthcare Sales & Marketing Network)– Spectranetics Corporation (Nasdaq:SPNC ) today announced six month interim results from the PATENT (Photo-Abl…
Devices, Interventional
Spectranetics, PATENT study, peripheral in-stent restenosis, laser atherectomy

Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis

Syneron Announces New Ground Breaking evolastin(TM) Procedure

admin — Thu, 02 Feb 2012 03:39:22 +0000

One treatment procedure primed to propel facial aesthetic procedures forward with unique results and significant science IRVINE, Calif., Feb. 2, 2012 (HSMN NewsFeed) — Syneron Pharma Ltd. (NASDAQ: ELOS ), www.syneron.com, the global leader in medica…
Devices, Dermatology
Syneron Pharma, evolastin procedure

Syneron Announces New Ground Breaking evolastin(TM) Procedure

Boston Scientific Announces First Implant and Market Launch of PROMUS Element(TM) Plus Stent System in Europe

admin — Wed, 01 Feb 2012 18:07:52 +0000

Platinum chromium coronary stent with enhanced delivery system now available in Europe and other international countries NATICK, Mass., Feb. 1, 2012 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) announces first patient use and European…
Devices, Interventional Cardiology
Boston Scientific, PROMUS Element, Platinum Chromium, drug eluting stent